Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-04-2006 | Review

Genomic screening of head and neck cancer and its implications for therapy planning

Author: Jan Akervall

Published in: European Archives of Oto-Rhino-Laryngology | Issue 4/2006

Abstract

Despite great technical improvements in radiotherapy and surgery, survival for patients with squamous cell carcinoma of the head and neck (SCCHN) has still not improved significantly over the last decades. Management of SCCHN has mainly been based on the TNM staging and site over this time period, even though we know that there are individual differences independent of the TNM status. Individual patients with small tumors might have a poor outcome, and patients with large tumors may end up with a favorable prognosis, despite their respective TNM classification. Recent molecular studies indicate that underlying genetic abnormalities may reflect such individual differences independently of TNM status. Individualization of treatment based on such biological properties of the tumors might result in less over as well as under treatment. However, the optimal panel of biomarkers to be used for the individualization of treatment is yet to be defined. A variety of laboratory techniques have been used in studies that investigate the individual biological features, spanning from methods that screen the genome for chromosomal and genetic abnormalities, e.g., cytogenetics, CGH, SKY and cDNA micro array, to detailed studies of specific aberrations. The purpose of this review of the literature is to summarize what has been studied so far by methods for genetic screening and to relate these results to the prediction of the clinical outcome. We conclude that it is time to focus future prospective studies on how treatment can be individualized based on biomarkers in combination with the macroscopic features of SCCHN.

Quon H, Liu F, Cummings B (2001) Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 23:147–159CrossRefPubMed

van’t Veer L, Dai H, van de Vijer M (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874CrossRefPubMed

Singh D, Febbo P, Ross K, Jackson D, Manola J, Ladd C, et al (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1:203–209CrossRefPubMed

Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F et al (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821PubMed

Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson R, et al (1996) Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 14:312–315CrossRefPubMed

Eisen M, Brown P (1991) DNA arrays for analysis of gene expression. Methods Enzymol 303:170–205

Gollin S (2001) Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23:238–253CrossRefPubMed

Gebhart E (2004) Comparative genomic hybridization (CGH): 10 years of substantial progress in human solid tumor molecular cytogenetics. Cytogenet Genome Res 104:352–358CrossRefPubMed

Brzoska P, Levin N, Fu K, Kaplan M, Singer M, Gray J, et al (1995) Frequent novel DNA copy number increase in squamous cell head and neck tumors. Cancer Res 15:3055–3059

10.

Speicher M, Howe C, Crotty P, du Manoir S, Costa J, Ward D (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55:1010–1013PubMed

11.

Bockmuhl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, et al (1997) Patterns of chromosomal imbalances in metastasizing and nonmetastasizing head and neck cancer. Cancer Res 57:5313–5316

12.

Bockmuhl U, Schluns K, Schmidt S, Matthias S, Petersen I (2002) Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 33:29–35CrossRefPubMed

13.

Patmore H, James N, Cawkwell L, MacDonald A, Stafford N, Greenman J (2004) Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation? Br J Cancer 90:1976–1982CrossRefPubMed

14.

Bockmuhl U, You X, Pacyna-Gengelbach M, Arps H, Draf W, Petersen I (2004) CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol 14:158–163PubMed

15.

Riazimand S, Brieger J, Jacob R, Welkoborsky H, Mann W (2002) Analysis of cytogenetic aberrations in esthesioneuroblastomas by comparative genomic hybridization. Cancer Genet Cytogenet 136:53–57CrossRefPubMed

16.

Bockmuhl U, Schwendel A, Dietel M, Petersen I (1996) Distinct patterns of chromosomal alterations in high and low grade head and neck squamous cell carcinomas. Cancer Res 56:5325–5329PubMed

17.

Schwerer M, Hemmer J, Kraft K, Maier H, Moller P, Barth T (2003) Endoreduplication in conjunction with tumor progression in an aneuploid laryngeal squamous cell carcinoma. Virchows Arch 443:98–103CrossRefPubMed

18.

Huang Q, Yu G, McCormick S, Mo J, Datta B, Mahimkar M, et al (2002) Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34:224–233CrossRefPubMed

19.

Golub T, Slonim D, Tamayo P, Huard C, Gaasenbeek M, Mesirov J, et al (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531–537CrossRefPubMed

20.

Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, Rosenwald A, et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503–511CrossRefPubMed

21.

Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F, et al (2003) Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarra analysis. Oncogene 23:2484–2498CrossRef

22.

Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, et al (2003) Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 89:1940–1949CrossRefPubMed

23.

Villaret D, Wang T, Dillon D, Xu J, Sivam D, Cheever M, et al (2000) Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 110:374–381CrossRefPubMed

24.

Sok J, Kuriakose M, Mahajan V, Pearlman A, DeLacure M, Chen F (2003) Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg 129:760–770CrossRefPubMed

25.

Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, et al (2001) Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 27:6196–6204CrossRef

26.

Leethanakul C, Knezevic V, Patel V, Amornphimoltham P, Gillespie J, Shillitoe E, et al (2003) Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol 39:248–258CrossRefPubMed

27.

Leethanakul C, Patel V, Gillespie J, Shillitoe E, Kellman R, Ensley J, et al (2000) Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol 36:474–483CrossRefPubMed

28.

Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley J, Koontongkaew S, et al (2000) Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19:3220–3224CrossRefPubMed

29.

Al Moustafa A, Alaoui-Jamali M, Batist G, Hernandez-Perez M, Serruya C, Alpert L, et al (2002) Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21:2634–2640CrossRefPubMed

30.

El-Naggar A, Kim H, Clayman G, Coombes M, Le B, Lai S, et al (2002) Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene 21:8206–8219CrossRefPubMed

31.

Mendez E, Cheng C, Farwell D, Ricks S, Agoff S, Futran N, et al (2002) Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 95:1482–1494CrossRefPubMed

32.

Schmalbach C, Chepeha D, Giordano T, Rubin M, Teknos T, Bradford C, et al (2004) Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:295–302CrossRefPubMed

33.

Nagata M, Fujita H, Ida H, Hoshina H, Inoue T, Seki Y, et al (2003) Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 106:683–689CrossRefPubMed

34.

Ito H, Hatori M, Kinugasa Y, Irie T, Tachikawa T, Nagumo M (2003) Comparison of the expression profile of metastasis-associated genes between primary and circulating cancer cells in oral squamous cell carcinoma. Anticancer Res 23:1425–1431PubMed

35.

Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F, et al (2004) Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23:2484–2498CrossRefPubMed

36.

Hu Y, Lam K, Law S, Wong J, Srivastava G (2001) Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. Clin Cancer Res 7:3519–3525PubMed

37.

Akervall J, Jin Y, Wennerberg J, Zatterstrom U, Kjellén E, Mertens F, et al (1995) Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 76:853–859PubMed

38.

Zaharieva B, Simon R, Diener P, Ackermann D, Maurer R, Alund G, et al (2003) High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 201:603–608CrossRefPubMed

39.

Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I (2000) Genetic imbalances with impact on survival in Head and Neck cancer patients. Am J Pathol 157:369–375PubMed

40.

Wreesmann V, Shi W, Thaler H, Poluri A, Kraus D, Pfister D, et al (2004) Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 22:3965–3972CrossRefPubMed

41.

Pearlstein R, Benninger M, Carey T (1998) Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 21:333–339CrossRefPubMed

42.

Wreesmann V, Sieczka E, Socci N, Hezel M, Belbin T, Childs G, et al (2004) Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res 64:3780–3789CrossRefPubMed

43.

Yoo G, Piechocki M, Ensley J, Nguyen T, Oliver J, Meng H, et al (2002) Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot. Clin Cancer Res 8:3910–3921PubMed

44.

Akervall J, Guo X, Qian C-N, Schoumans J, Cole A, Leeser B, et al (2004) Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin Cancer Res 10:8204–8213CrossRefPubMed

45.

Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, et al (2001) Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 61:6474–6479PubMed

46.

Belbin T, Singh B, Barber I, Socci N, Wenig B, Smith R, et al (2002) Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 62:1184–1190PubMed

47.

Ishibashi Y, Hanyu N, Nakada K, Suzuki Y, Yamamoto T, Yanaga K, et al (2003) Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma. Cancer Res 63:5159–5164PubMed

48.

Genden E, Ferlito A, Bradley P, Rinaldo A, Scully C (2003) Neck disease and distant metastases. Oral Oncol 39:207–212CrossRefPubMed

Title: Genomic screening of head and neck cancer and its implications for therapy planning
Author: Jan Akervall
Publication date: 01-04-2006
Publisher: Springer-Verlag
Published in: European Archives of Oto-Rhino-Laryngology / Issue 4/2006
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-006-1039-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Genomic screening of head and neck cancer and its implications for therapy planning

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2006

A case of metastatic hepatocellular carcinoma in the nasal cavity

Acute tonsillitis: an unusual presentation of Kawasaki syndrome: a case report and review of the literature

A comparative study of voice complaints and risk factors for voice complaints in female student teachers and practicing teachers early in their career

Confirmation of mucin in lymphatic vessels of acquired cholesteatoma

The role of computed tomography in endoscopic sinus surgery: a review of 10 years’ practice

An autologous system for culturing head and neck squamous cell carcinomas for the assessment of cellular therapies on the chorioallantois membrane